1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Intracardiac thrombus in a patient with catastrophic antiphospholipid syndrome: an autopsy case report and review of the literature

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Antiphospholipid syndrome (APS) is an autoantibody-mediated acquired thrombophilia characterized by venous and/or arterial thromboses, pregnancy morbidity (predominantly repeated fetal losses), and the presence of phospholipid antibodies. The estimated annual incidence of APS is 5 new cases per 100,000 people. The most common thrombotic events in patients with APS in order of frequency are stroke, transient ischemic attack, deep vein thrombosis, and pulmonary embolism. Patients with APS may develop an intracardiac thrombus, which is a life-threatening complication with a high risk of increased morbidity and mortality; however, it is treatable by surgical removal, extensive anticoagulant administration, and prevention of other complications. Catastrophic APS, which is a rare and severe condition diagnosed based on rapidly progressive thromboembolic events involving three or more organs, systems, or tissues, occurs in less than 1% of all patients with APS. We herein report an autopsy case of catastrophic APS in a 12-year-old Thai boy with multiple thromboembolic events including intracardiac thrombus formation with a positive lupus anticoagulant test result. To the best of our knowledge, this is the youngest reported patient with APS to date.

          Related collections

          Most cited references18

          • Record: found
          • Abstract: not found
          • Article: not found

          The antiphospholipid syndrome.

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Pathogenesis of antiphospholipid syndrome: understanding the antibodies.

            Antiphospholipid antibodies (aPL) are both diagnostic markers for, and pathogenic drivers of, antiphospholipid syndrome (APS). Although the presence of aPL is a necessary pre-condition, APS-associated clotting is seemingly triggered by an additional 'second hit', frequently related to innate inflammatory immune responses. β(2) glycoprotein I (β(2)GPI)-dependent aPL, the most important subset of these antibodies, mediate several--not necessarily alternative--thrombogenic mechanisms, mainly on the basis of their reactivity with β(2)GPI expressed on the membrane of cells that participate in the coagulation cascade. Recurrent pregnancy complications associated with aPL cannot be explained solely by thrombosis, and alternative pathogenic mechanisms have been reported. Although one in vivo model of fetal loss suggests a mechanism of aPL-mediated acute placental inflammation, other models and the histopathological examination of APS placentae do not support a widespread inflammatory signature. β(2)GPI-dependent aPL are thought to recognize their antigen on placental tissues, inhibit the growth and differentiation of trophoblasts, and eventually cause defective placentation. Why antibodies with similar antigen specificity produce different clinical manifestations is not clear. Characterization of the molecular basis of the pathogenic mechanisms involved, including the putative second hits and the role of complement activation, might offer an answer to this question.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry.

              To analyze the clinical and immunologic manifestations of patients with catastrophic antiphospholipid syndrome (CAPS) from the "CAPS Registry".
                Bookmark

                Author and article information

                Journal
                Vasc Health Risk Manag
                Vasc Health Risk Manag
                VHRM
                vhriskman
                Vascular Health and Risk Management
                Dove
                1176-6344
                1178-2048
                07 August 2019
                2019
                : 15
                : 253-258
                Affiliations
                [1 ] Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University , Bangkok, Thailand
                [2 ] Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University , Bangkok, Thailand
                Author notes
                Correspondence: Jariya Waisayarat, Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University , 270 Rama VI Road, Rajathevee, Bangkok10400, ThailandTel +66 2 201 1432Fax +66 2 354 7266Email jariya.wai@mahidol.ac.th
                Author information
                http://orcid.org/0000-0002-6744-6424
                http://orcid.org/0000-0003-2331-9711
                http://orcid.org/0000-0001-8039-5476
                Article
                197638
                10.2147/VHRM.S197638
                6690037
                31496715
                5c1b1db4-edde-41a5-8b64-1464b2d09046
                © 2019 Waisayarat et al.

                This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

                History
                : 12 December 2018
                : 16 July 2019
                Page count
                Figures: 2, Tables: 1, References: 23, Pages: 6
                Categories
                Case Report

                Cardiovascular Medicine
                antiphospholipid syndrome,intracardiac thrombus,catastrophic antiphospholipid syndrome,antiphospholipid antibodies

                Comments

                Comment on this article